ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1138

Nonpharmacologic and Pharmacologic Therapy Utilization by Primary Care Providers for Hand Osteoarthritis-Comparative Review by Electronic Health Record Data Mining and in-Home Visit Verification

Gale A. McCarty, President, Rheum.Ed Consulting, Harborside, ME

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: To compare current utilization of usual nonpharmacologic (NP) and pharmacologic (P) therapies for hand osteoarthritis (OA) by primary care providers (PCPs) and patients (Pts) based on American College of Rheumatology (ACR) 2012 Recommendations in 2 age- and gender-matched populations.

Methods: From voluntary in-home health visit (problem list, history, exam, medication reconciliation) with electronic health record assessment over 3 yrs for ascertainment of Medicare Advantage general health maintenance and quality benchmarking (Cty 1-Sacramento County CA, N = 50,  and Cty 2-Cumberland County ME, N = 50), age- and gender-matched pts were identified. Pts were unaware the examiner was a rheumatologist. Discussion vs. Use vs. Source (PCP or pt) of NP recommendations (Activities of Daily Living, ADLs/Jt Protection/Assistive Device Provision for ADLs/Thermal Modalities/TrapezioMCP Splints) and P recs (Top. Capsaicin/Top. NSAIDs/PO NSAIDs/Tramadol) were queried. Descriptive statistics and/or SPlus were used where applicable: p value significance was Results: Results:  Behavior Risk Factor Surveillance System 2009/10 data confirmed no significant differences (nsd) from Cty 1 vs Cty 2 in: population (281,674 vs 265,012), % pop. > 65 (10.6 vs 11.2%), white ethnicity (78% vs 80%), female gender (70 vs 72%), mean age (72.4 vs 74.1 yrs-range 65-98), no. of pts. w/ doctor-diagnosed arthritis  b/w ages of 65 and 74 (45 vs 53%), no. of pts. w/ activity limitation due to arthritis (48 vs 44%), no. of pts w/ social participation restriction due to arthritis (17 vs 14%), no. of pts w/ severe pain due to arthritis-non-site specified (27 vs 21%), obesity by BMI (32 vs 33%), the no. of Rheumatologists available for referral in network (6 vs 7), and the % of benchmarks attained for major health metrics (96 vs 95% capture). Latino ethnicity was statistically different (16.6 vs 1.9%). No significant differences from Cty 1 vs Cty 2 were noted for: Dx of OA-Hands (88 vs 92%); all had discussed OA as an issue with their PCPs at least once in the prior 3 yrs. Presence of hand OA was confirmed by Rheumatology exam in 88 vs 92% of pts. At least 1 NP Rec (Thermal Modalities) and 1 P Rec (Top NSAIDS) had been discussed at least once for all pts. by PCPs (100 vs 100%), but utilization was significantly different (44 vs 22%). Jt Protection and ADLs had not been discussed or utilized (80 vs 80%); only Assistive Device Provision (cane/walker) had been done (33 vs 30%). PO NSAIDs were actively discouraged even in low dose/Cox2 selective/H2 blocker usage by providers (80% vs 80%).

Conclusion:

Current NP and P recommendations from OA experts are variably implemented with pts, despite confirmed presence of OA by their own PCPs as an Active Problem, and pts. reporting pain and social restriction due to arthritis.


Disclosure:

G. A. McCarty,
None;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nonpharmacologic-and-pharmacologic-therapy-utilization-by-primary-care-providers-for-hand-osteoarthritis-comparative-review-by-electronic-health-record-data-mining-and-in-home-visit-verification/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology